News

Filter

Current filters:

None

7876 to 7885 of 96312 results

GSK settles with Genentech over ofatumumab patents

28-03-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed a settlement with Genentech, a unit of Roche (ROG:…

ArzerraBiotechnologyGenentechGenmabGlaxoSmithKlineLegalOfatumumab InjectionOncologyPatentsPharmaceuticalRoche

Panacea Biotech inaugurates new cancer drug facility in India

28-03-2012

Indian health care management company Panacea Biotec says that it has inaugurated a new state-of-the-art…

Asia-PacificBiotechnologyFinancialMarkets & MarketingPanacea Biotec

Thrombolytics safe for treating moderate pulmonary embolism

28-03-2012

Pulmonary embolism - the sudden blockage of an artery in the lung - is estimated to cause over 100,000…

Cardio-vascularPharmaceuticalResearch

FDA delay for MAP Pharma migraine drug candidate

28-03-2012

Shares of USA-based MAP Pharmaceuticals (Nasdaq: MAPP) plunged 24% to $13.01 in early trading yesterday,…

AllerganLevadexMAP PharmaceuticalsMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalRegulation

Sanofi and Bayer consider Russian expansion, product launches

28-03-2012

Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

Astellas files for EU approval of EC905, EMA accepts avanafil filing

28-03-2012

The European subsidiary of Japanese drug major Astellas Pharma (Tokyo: 4503) has announced the submission…

Astellas PharmaavanafilEuropeMen's HealthPharmaceuticalRegulationVivus

7876 to 7885 of 96312 results

Back to top